Mutational Landscape of Bone Marrow Cells in Waldenström Macroglobulinemia and IgM MGUS
Author Information
Author(s): Alessandra Trojani, Alessandro Beghini, Luca Emanuele Bossi, Marta Rachele Stefanucci, Cassandra Palumbo, Antonino Greco, Annamaria Frustaci, Barbara Di Camillo, Roberto Cairoli
Primary Institution: Niguarda Hospital Department of Hematology and Oncology Milano Italy
Hypothesis
The genetic basis for Waldenström's Macroglobulinemia (WM) and the risk of progression of IgM MGUS to WM remain to be fully elucidated.
Conclusion
The study uncovered new insights into the mutational landscape of WM, depicting a more complex involvement of the NF-kB pathway.
Supporting Evidence
- 93% of WM/sWM patients had the MYD88L265P mutation.
- 60% of IgM MGUS patients also had the MYD88L265P mutation.
- New mutations were identified in genes like WNK2 and BCL9.
Takeaway
Researchers looked at the genes in bone marrow cells from patients with two types of blood disorders and found new mutations that could help understand how these diseases develop.
Methodology
Next-generation sequencing (NGS) was performed on 20 patients to analyze the mutation status of selected genes.
Limitations
The study had a small number of patients with sWM/WM and IgM MGUS, which may limit the generalizability of the findings.
Participant Demographics
{"total":20,"WM":15,"IgM_MGUS":5,"median_age":67,"sex_distribution":{"male":10,"female":10}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website